PTPRC and Miyoshi myopathy: Accordingly, treatment of CD45+ MM cells with thapsigargin, an inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), increases cytosolic levels of Ca2+ and triggers apoptosis in VDAC1-expressing MM cells (Figure 1) [75].